Advertisement

AstraZeneca, Cephalon to pay to resolve Medicaid allegations - U.S

WASHINGTON (Reuters) - AstraZeneca LP has agreed to pay $46.5 million (£29.81 million) and Cephalon Inc [TEVAE.UL] $7.5 million to resolve allegations that the two drug companies underpaid rebates owed under the Medicaid program, the U.S. Justice Department said on Monday.

(Reporting by Eric Beech; Editing by Bill Trott)